CGEN
Compugen
NASDAQ: CGEN · HEALTHCARE · BIOTECHNOLOGY
$2.66
+2.31% today
Updated 2026-04-30
Market cap
$268.77M
P/E ratio
7.45
P/S ratio
3.69x
EPS (TTM)
$0.38
Dividend yield
—
52W range
$1 – $3
Volume
0.4M
Compugen (CGEN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |